Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

UK charity launches assault on deadliest cancers

Cancer Research UK is to fund more work on pancreatic, lung and oesophageal cancer and will open up to 20 more research centres as part of its plans to disburse £1.5 billion (US$2.3 billion) over the next five years. The charity, the world's largest independent funder of cancer research, already provides core funding for seven dedicated cancer institutes in Britain.

Compared with other cancers, such as prostate and breast cancer, for which survival rates have improved, "essentially no progress" has been made in preventing deaths from pancreatic, lung and oesophageal cancers, says Harpal Kumar, Cancer Research UK's chief executive.

The charity recently delayed making decisions on applications for project grants, due in January 2009, until April. But it will press ahead with its five-year strategy commitment despite the financial downturn. "We are weathering the storm," says Kumar.

Additional information

Click here for a longer version of this story.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

UK charity launches assault on deadliest cancers. Nature 456, 558 (2008). https://doi.org/10.1038/456558a

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing